Sofosbuvir (Solvaldi®)

Assessment Status Assessment process complete
Drug Sofosbuvir
Brand Solvaldi®
Indication In combination with other medicinal products for the treatment of Chronic Hepatitis C in adults.
Assessment Process
Rapid review commissioned 12/02/2014
Rapid review completed 10/03/2014
Rapid review outcome Full Pharmacoeconomic Evaluation Recommended
Full submission received from Applicant 03/06/2014
NCPE assessment outcome  Reimbursement Recommended for certain subgroups